A detailed history of Cullen Investment Group, Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 19,804 shares of EW stock, worth $1.5 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
19,804
Previous 19,456 1.79%
Holding current value
$1.5 Million
Previous $1.8 Billion 27.28%
% of portfolio
0.19%
Previous 0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$59.7 - $93.78 $20,775 - $32,635
348 Added 1.79%
19,804 $1.31 Billion
Q2 2024

Jul 01, 2024

BUY
$84.3 - $94.31 $16,607 - $18,579
197 Added 1.02%
19,456 $1.8 Billion
Q1 2024

Apr 04, 2024

BUY
$72.54 - $95.56 $84,944 - $111,900
1,171 Added 6.47%
19,259 $1.82 Billion
Q4 2023

Jan 30, 2024

BUY
$61.71 - $77.76 $1.12 Million - $1.41 Million
18,088 New
18,088 $1.38 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cullen Investment Group, Ltd. Portfolio

Follow Cullen Investment Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Investment Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Cullen Investment Group, Ltd. with notifications on news.